Account
Publicis co Zenith wins Lactalis’ media duties
MUMBAI: As part of a global multi-agency pitch, Zenith has won the media duties of French dairy giant Lactalis. Zenith now handles the business in 26 countries, which includes India.
Lactalis is a leader within the dairy industry, and is present across all the dairy categories of this market. The Group is the number one cheese manufacturer in the world, and the European leader within the milk consumption, butter and cream markets. It is also a major player in the chilled dairy and dairy ingredients categories, as well as the food service industry, and a growing player within clinical and infant nutrition markets.
Zenith India Group CEO Tanmay Mohanty said, “The company shares our values, ambition and drive. Lactalis has a long-term vision for the Indian market; it stands for quality products and we would love to partner with them in building this category and market leadership. Our newly launched ROI+ proposition with advanced communications models and sharper focus on analytics, tech, data and consumer insights will take Lactalis even further in a high growth Indian dairy market. This win adds tempo to a great year where we have won significant businesses and consolidated operations.”
Zenith is part of Publicis Media, one of four solution hubs within Publicis Groupe [Euronext Paris FR0000130577, CAC40], and has offices within Publicis One. In India, Zenith’s key clients include Nestlé, Parle Products, Micromax, LVMH Group, Toyota, Bombay Dyeing, H&M, Singapore Tourism Board, Fox Networks, BASF and Singapore Airlines among others.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
